Cited 0 time in
Collaborative Study to Establish National Reference Standards for Anti-HIV-1 Antibody
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Huh, Hee Jin | - |
| dc.contributor.author | Kim, Soo-Kyung | - |
| dc.contributor.author | Chung, Jae-Woo | - |
| dc.contributor.author | Yoo, Soo Jin | - |
| dc.contributor.author | Roh, Kyoung Ho | - |
| dc.contributor.author | Chae, Seok Lae | - |
| dc.contributor.author | Cha, Young Joo | - |
| dc.date.accessioned | 2024-08-08T10:01:51Z | - |
| dc.date.available | 2024-08-08T10:01:51Z | - |
| dc.date.issued | 2023-05 | - |
| dc.identifier.issn | 2234-3806 | - |
| dc.identifier.issn | 2234-3814 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/21332 | - |
| dc.description.abstract | Background: National reference standards for anti-HIV-1 antibody are needed to evaluate the performance and maintain the quality control of anti-HIV-1 antibody assays. The aim of this study was to prepare a mixed-titer performance panel and assess its suitability as a national reference standard for anti-HIV-1 antibody according to stability, collaboration, and other studies.Methods: Nineteen serum samples from different HIV patients were obtained, along with 15 units of fresh frozen plasma samples with negative anti-HIV-1 antibody results. Ten anti -HIV-1 antibody-positive candidate standards and two negative candidate standards were prepared based on the reactivity in the Alinity i HIV Ag/Ab combo assay (Abbott Laborato-ries, Wiesbaden, Germany). A collaborative study was conducted across eight laboratories using five anti-HIV-1 antibody assays. Real-time and accelerated stability were evaluated to assess the long-term stability.Results: In the collaborative study, results of all five anti-HIV-1 antibody assays were posi-tive for all 10 candidate standards prepared using HIV patient samples. The CV of each as-say for every candidate standard was within 10%, except for one assay result. No real-time and accelerated stability change trend was observed at -70 degrees C or -20 degrees C, supporting that the reference standards were maintained in a stable state at -70 degrees C for long-term storage. Conclusions: The overall results suggest that the 12 candidate standards could serve as national reference standards for anti-HIV-1 antibody. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한진단검사의학회 | - |
| dc.title | Collaborative Study to Establish National Reference Standards for Anti-HIV-1 Antibody | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3343/alm.2023.43.3.273 | - |
| dc.identifier.scopusid | 2-s2.0-85144596074 | - |
| dc.identifier.wosid | 000906791300008 | - |
| dc.identifier.bibliographicCitation | Annals of Laboratory Medicine, v.43, no.3, pp 273 - 279 | - |
| dc.citation.title | Annals of Laboratory Medicine | - |
| dc.citation.volume | 43 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 273 | - |
| dc.citation.endPage | 279 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002950934 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Medical Laboratory Technology | - |
| dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
| dc.subject.keywordPlus | HIV-1 | - |
| dc.subject.keywordAuthor | Anti-HIV-1 antibody | - |
| dc.subject.keywordAuthor | HIV | - |
| dc.subject.keywordAuthor | Reference standard | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
